MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 05-16-2026
NeuroMetrix General and Administrative Expenses 2011-2026 | NURO
General and Administrative Expenses — these are a part of a company's operating expenses that are not directly related to the production of goods or the provision of services but are necessary for the overall functioning of the business.What these expenses include
- Salaries of administrative staff (executives, HR, accountants, legal personnel)
- Office rent and utilities
- Office equipment and IT infrastructure
- Professional services (auditors, lawyers, consultants)
- Insurance
- General administrative travel and representation expenses
- Cost control
A high level of such expenses may indicate inefficient management or an overly complex structure - Profitability
Reducing administrative expenses while maintaining stable revenue increases operating profit - Comparative analysis
Investors can compare this metric as a percentage of revenue among companies in the same industry - Business flexibility
Companies with a flexible and controlled expense structure are more resilient to revenue declines
Annual General and Administrative Expenses NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.33 M | 4.96 M | 4.39 M | 3.99 M | 3.52 M | 5.92 M | 4.84 M | 5.69 M | 4.87 M | 5.5 M | 4.73 M | 4.23 M | 4.74 M | 5.11 M | 7.23 M | 9.12 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 9.12 M | 3.52 M | 5.32 M |
Quarterly General and Administrative Expenses NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.31 M | 1.62 M | 1.77 M | - | 1.21 M | 1.24 M | 1.39 M | - | 1.1 M | 1.18 M | 1.19 M | - | 966 K | 1.28 M | 1.01 M | - | 763 K | 678 K | 1.25 M | - | 1.46 M | 1.56 M | 1.62 M | - | 1.02 M | 1.17 M | 1.8 M | - | 1.26 M | 1.25 M | 1.42 M | - | 1.17 M | 1.29 M | 1.42 M | - | 1.39 M | 1.22 M | 1.55 M | - | 1.31 M | 1.15 M | 1.15 M | - | 1.01 M | 992 K | 1.23 M | - | 1.15 M | 1.38 M | 1.19 M | - | 1.2 M | 1.3 M | 1.38 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 M | 678 K | 1.26 M |
General and Administrative Expenses of other stocks in the Medical instruments industry
| Issuer | General and Administrative Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
23.2 K | - | - | $ 810 M |  USA |
 |
The Cooper Companies
COO
|
1.63 B | $ 67.81 | -1.18 % | $ 13.5 B | USA |
 |
Glaukos Corporation
GKOS
|
332 M | $ 120.74 | -4.5 % | $ 6.91 B | USA |
 |
Luminex Corporation
LMNX
|
140 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
3.73 M | - | -9.52 % | $ 20.6 M | USA |
 |
Intuitive Surgical
ISRG
|
2.38 B | $ 420.65 | -1.4 % | $ 150 B | USA |
 |
Alcon
ALC
|
251 M | $ 67.02 | -1.3 % | $ 40.4 B |  Schweiz |
 |
ICU Medical
ICUI
|
625 M | $ 142.61 | 0.43 % | $ 3.51 B | USA |
 |
Repro Med Systems
KRMD
|
23.4 M | $ 3.98 | -0.5 % | $ 184 M | USA |
 |
iRhythm Technologies
IRTC
|
493 M | $ 115.57 | 1.53 % | $ 3.7 B | USA |
 |
LeMaitre Vascular
LMAT
|
42 M | $ 96.58 | -0.01 % | $ 2.19 B | USA |
 |
Masimo Corporation
MASI
|
744 M | $ 179.95 | - | $ 9.59 B | USA |
 |
Antares Pharma, Inc.
ATRS
|
62.8 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
198 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
8.44 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
941 M | - | -0.05 % | $ 10.3 B | USA |
 |
Microbot Medical
MBOT
|
8.46 M | $ 1.83 | 0.27 % | $ 83.8 M |  Israel |
 |
Ekso Bionics Holdings
EKSO
|
9.99 M | - | - | $ 28.6 M | USA |
 |
Milestone Scientific
MLSS
|
11.6 M | $ 0.4 | 2.79 % | $ 32.8 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
671 M | - | -0.02 % | $ 16.3 B | USA |
 |
Merit Medical Systems
MMSI
|
455 M | $ 67.15 | -0.54 % | $ 3.97 B | USA |
 |
electroCore
ECOR
|
38.2 M | $ 9.84 | 3.36 % | $ 83.5 K | USA |
 |
Envista Holdings Corporation
NVST
|
1.16 B | $ 24.65 | 0.24 % | $ 4.14 B | USA |
 |
Haemonetics Corporation
HAE
|
442 M | $ 79.88 | 1.45 % | $ 3.77 B | USA |
 |
STERIS plc
STE
|
1.41 B | $ 211.1 | -0.84 % | $ 20.7 B | USA |
 |
Isoray
ISR
|
30.2 M | - | 0.03 % | $ 108 M | USA |
 |
STAAR Surgical Company
STAA
|
85.8 M | $ 29.81 | -0.2 % | $ 1.48 B | USA |
 |
InfuSystem Holdings
INFU
|
57 M | $ 9.13 | 1.11 % | $ 189 M | USA |
 |
Teleflex Incorporated
TFX
|
720 M | $ 136.49 | 0.55 % | $ 6.09 B | USA |
 |
Utah Medical Products
UTMD
|
7.88 M | $ 69.08 | 1.48 % | $ 224 M | USA |
 |
West Pharmaceutical Services
WST
|
394 M | $ 333.67 | -0.37 % | $ 24.1 B | USA |
 |
Pulse Biosciences
PLSE
|
32 M | $ 25.05 | -2.79 % | $ 1.69 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.44 B | $ 10.52 | 0.43 % | $ 2.1 B | USA |
 |
Retractable Technologies
RVP
|
12.8 M | $ 0.69 | -0.16 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
4.84 M | $ 65.1 | 0.15 % | $ 214 M | USA |
 |
Predictive Oncology
POAI
|
25.9 M | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
45.5 M | $ 27.8 | 0.91 % | $ 1.33 B | USA |
 |
Stereotaxis
STXS
|
17.8 M | $ 1.87 | 1.08 % | $ 170 M | USA |
 |
Baxter International
BAX
|
2.89 B | $ 20.93 | 4.49 % | $ 10.7 B | USA |
 |
ResMed
RMD
|
739 M | $ 195.8 | -0.58 % | $ 28.6 B | USA |
 |
AtriCure
ATRC
|
311 M | $ 27.42 | 0.44 % | $ 1.31 B | USA |
 |
Harvard Bioscience
HBIO
|
17.7 M | $ 6.3 | 4.3 % | $ 280 M | USA |
 |
AngioDynamics
ANGO
|
42.1 M | $ 12.47 | 1.05 % | $ 509 M | USA |
 |
Becton, Dickinson and Company
BDX
|
5.28 B | $ 150.22 | -1.2 % | $ 43.2 B | USA |
 |
Nephros
NEPH
|
9 M | $ 3.19 | -1.82 % | $ 33.9 M | USA |
 |
OraSure Technologies
OSUR
|
47.7 M | $ 4.26 | 0.59 % | $ 313 M | USA |
 |
Repligen Corporation
RGEN
|
291 M | $ 134.67 | 3.49 % | $ 7.57 M | USA |